Profile data is unavailable for this security.
About the company
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Company’s three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.
- Revenue in USD (TTM)2.57bn
- Net income in USD615.26m
- Incorporated2007
- Employees7.17k
- LocationVeeva Systems Inc4280 Hacienda DrivePLEASANTON 94588United StatesUSA
- Phone+1 (925) 452-6500
- Fax+1 (925) 452-6504
- Websitehttps://www.veeva.com/medtech/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cooper Companies Inc | 3.80bn | 359.30m | 19.90bn | 15.00k | 55.64 | 2.51 | 27.03 | 5.23 | 1.80 | 1.80 | 19.02 | 39.80 | 0.3196 | 1.70 | 5.56 | 253,606.70 | 3.02 | 10.06 | 3.29 | 11.34 | 66.36 | 65.54 | 9.45 | 29.00 | 1.18 | 5.46 | 0.2493 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 0.00 |
| Steris PLC | 5.12bn | 602.62m | 21.30bn | 18.18k | 35.51 | 3.23 | 19.23 | 4.16 | 6.08 | 4.38 | 51.62 | 66.80 | 0.4758 | 3.86 | 5.49 | 281,655.40 | 5.62 | 5.19 | 6.10 | 5.68 | 43.01 | 43.64 | 11.81 | 10.97 | 1.55 | 8.29 | 0.2528 | 36.56 | 13.28 | 13.06 | -1.07 | 12.67 | 13.69 | 8.83 |
| Zimmer Biomet Holdings Inc | 7.60bn | 1.08bn | 21.58bn | 18.00k | 20.65 | 1.75 | 10.48 | 2.84 | 5.25 | 5.25 | 36.87 | 62.00 | 0.3538 | 0.9136 | 5.38 | 421,972.20 | 5.05 | 2.21 | 5.82 | 2.52 | 71.78 | 71.25 | 14.28 | 7.28 | 0.6987 | 7.52 | 0.3425 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| Illumina Inc | 4.39bn | -1.58bn | 21.73bn | 10.59k | -- | 10.25 | -- | 4.95 | -10.00 | -10.00 | 27.61 | 13.36 | 0.5441 | 2.66 | 6.17 | 414,542.00 | -19.63 | -6.20 | -23.16 | -7.28 | 63.94 | 66.39 | -36.08 | -15.48 | 1.85 | 38.44 | 0.4834 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
| Waters Corp | 2.91bn | 622.64m | 21.88bn | 7.90k | 35.16 | 13.65 | 26.86 | 7.53 | 10.48 | 10.48 | 48.89 | 27.00 | 0.645 | 2.20 | 4.47 | 367,740.10 | 13.82 | 19.77 | 16.72 | 25.29 | 59.73 | 58.45 | 21.43 | 23.38 | 1.38 | 10.11 | 0.5325 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
| West Pharmaceutical Services Inc. | 2.88bn | 499.60m | 23.24bn | 10.60k | 47.55 | 8.45 | 36.64 | 8.08 | 6.75 | 6.75 | 38.86 | 37.96 | 0.7743 | 4.50 | 5.51 | 271,358.50 | 13.02 | 15.61 | 15.16 | 18.65 | 34.87 | 38.06 | 16.81 | 18.47 | 2.23 | -- | 0.0695 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| DexCom Inc | 3.95bn | 680.80m | 29.08bn | 9.60k | 45.45 | 14.70 | 32.56 | 7.36 | 1.64 | 1.64 | 9.52 | 5.07 | 0.6107 | 2.76 | 4.42 | 411,875.00 | 10.51 | 8.30 | 14.28 | 10.50 | 62.10 | 65.90 | 17.22 | 14.14 | 2.12 | -- | 0.5579 | 0.00 | 24.49 | 28.56 | 58.70 | -- | 28.66 | -- |
| IDEXX Laboratories, Inc. | 3.84bn | 866.24m | 34.27bn | 11.00k | 40.38 | 21.22 | 34.54 | 8.91 | 10.36 | 10.36 | 46.00 | 19.72 | 1.19 | 3.85 | 7.14 | 349,528.80 | 26.91 | 28.00 | 38.86 | 43.49 | 60.72 | 58.74 | 22.53 | 21.35 | 1.03 | 59.10 | 0.3507 | 0.00 | 8.72 | 10.59 | 24.44 | 17.39 | 1.68 | -- |
| Veeva Systems Inc | 2.57bn | 615.26m | 34.74bn | 7.17k | 55.66 | 6.70 | 53.30 | 13.50 | 3.85 | 3.85 | 15.69 | 32.04 | 0.4453 | -- | 6.27 | 358,846.80 | 10.65 | 11.97 | 12.97 | 15.36 | 73.35 | 72.00 | 23.91 | 23.74 | -- | -- | 0.00 | 0.00 | 9.68 | 22.35 | 7.79 | 18.00 | 21.68 | -- |
| Resmed Inc | 4.81bn | 1.11bn | 35.76bn | 9.98k | 32.29 | 6.88 | 27.73 | 7.44 | 7.54 | 7.54 | 32.59 | 35.39 | 0.6886 | 2.17 | 6.08 | 481,711.90 | 15.94 | 14.24 | 18.11 | 16.53 | 57.67 | 56.85 | 23.15 | 20.35 | 1.91 | 44.71 | 0.1154 | 32.62 | 10.95 | 12.44 | 13.75 | 19.98 | 8.23 | 5.34 |
| GE HealthCare Technologies Inc | 19.56bn | 1.68bn | 37.46bn | 51.00k | 22.46 | 4.50 | 16.20 | 1.92 | 3.65 | 3.65 | 42.63 | 18.20 | 0.5906 | 5.40 | 4.41 | 383,490.20 | 5.22 | -- | 6.97 | -- | 41.33 | -- | 8.84 | -- | 0.982 | 5.67 | 0.5478 | -- | 6.60 | -- | -26.82 | -- | -- | -- |
| Agilent Technologies Inc | 6.50bn | 1.41bn | 37.94bn | 17.40k | 27.46 | 6.43 | 22.82 | 5.84 | 4.81 | 4.81 | 22.14 | 20.53 | 0.5996 | 2.87 | 5.06 | 358,950.30 | 13.04 | 11.00 | 16.13 | 13.25 | 54.75 | 53.29 | 21.75 | 18.01 | 1.37 | 55.86 | 0.3319 | 21.46 | -0.219 | 6.82 | -1.12 | 7.39 | 10.98 | 8.86 |
| Edwards Lifesciences Corp | 5.62bn | 1.43bn | 41.51bn | 19.80k | 29.72 | 4.35 | 26.57 | 7.38 | 2.37 | 6.93 | 9.32 | 16.18 | 0.5032 | 1.12 | 7.72 | 283,904.00 | 12.76 | 16.63 | 14.98 | 19.12 | 78.63 | 76.71 | 25.35 | 24.84 | 2.89 | -- | 0.0585 | 0.00 | 11.56 | 10.03 | -7.85 | 13.70 | 1.96 | -- |
| Cencora Inc | 293.96bn | 1.51bn | 48.41bn | 42.00k | 32.73 | 61.54 | 18.37 | 0.1647 | 7.51 | 7.51 | 1,467.70 | 3.99 | 4.53 | 15.59 | 12.44 | -- | 2.34 | 1.12 | 11.51 | 4.83 | 3.35 | 3.25 | 0.5168 | 0.2556 | 0.5291 | 19.37 | 0.848 | 65.38 | 12.12 | 10.36 | -13.53 | 13.02 | 9.45 | 4.98 |
Data as of Nov 22 2024. Currency figures normalised to Veeva Systems Inc's reporting currency: US Dollar USD
30.89%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 14.04m | 8.67% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 6.82m | 4.21% |
| AllianceBernstein LPas of 30 Sep 2024 | 6.21m | 3.83% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2024 | 4.99m | 3.08% |
| Massachusetts Financial Services Co.as of 30 Sep 2024 | 3.55m | 2.19% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 3.29m | 2.03% |
| T. Rowe Price Associates, Inc. (IM)as of 30 Sep 2024 | 3.17m | 1.96% |
| Geode Capital Management LLCas of 30 Sep 2024 | 2.77m | 1.71% |
| Artisan Partners LPas of 30 Sep 2024 | 2.62m | 1.62% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 2.56m | 1.58% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
